A Phase 1 interventional study of Clobetasol propionate 0.05 % ointment and Betamethasone dipropionate 0.064 % ointment in Skin and Connective Tissue Diseases, sponsored by LEO Pharma. Completed at 1 site in Germany. Open to male participants aged 25 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-02-24.
Sponsored by LEO Pharma · Phase 1, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The purpose of this study is to assess steroid induced skin atrophy by sonography.
20 studies on the registry are indexed under Skin and Connective Tissue Diseases; 6 are open to participants now.
This study's enrollment of 16 is below the median of 35 across 19 interventional studies indexed under Skin and Connective Tissue Diseases.
Browse Skin and Connective Tissue Diseases studies →LEO Pharma is the lead sponsor of 225 studies on the registry; 5 are open to participants now.
Of its 32 completed or terminated interventional studies of FDA-regulated products, 24 (75%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Active drug
Drug: Clobetasol propionate 0.05 % ointment
Active drug
Drug: Betamethasone dipropionate 0.064 % ointment
Placebo drug
Drug: Petrolatum ointment
Change in skin thickness from baseline to end of treatment
Time frame: 4 weeks
Relation of clinical features (skin transparency and telangiectasia) to the steroid induced skin atrophy after end of treatment
Time frame: 4 weeks
Plan to share: No
The record gives a start of Jan 2015, a primary completion of Apr 2015 and a completion of Apr 2015. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in May 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Clobetasol · Betamethasone dipropionate
Skin and Connective Tissue Diseases →